pre_text: NantHealth, Inc Consolidated Statements of Cash Flows (Continued) (Dollars in thousands) (1) Cash and cash equivalents included restricted cash of $1,136, $1,136, and $350 at December 31, 2019, 2018, and 2017 included in other assets, respectively. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal related to the Company's security deposits in the form of standby letters of credit for leased facilities. No amounts have been drawn upon the letters of credit as of December 31, 2019. The accompanying notes are an integral part of these Consolidated Financial Statements.
table: Year Ended December 31,
table: 2019 2018
table: Supplemental disclosure of cash flow information
table: Income taxes paid $318 $15
table: Interest paid $5,909 $5,885
table: Interest received — 13
table: Noncash investing and financing activities
table: Purchases of property and equipment (including internal use software) 1,068 529
table: Assignment of NantHealth Labs (see Note 20) — 8,956
question: Analyse this data from a financial earnings document. What is the average interest paid by the company in 2018 and 2019?